Skip to main content

Animations

MJFF Publications

7271 - 7280 of 9148 Results
Title
Year
  • Year
  • 2014
  • 2025
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • Summary Details
    OPEN
    Title: Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1042/bj20140334
    Citation Count: 816
  • Summary Details
    OPEN
    Title: Impact of Y chromosome loss on the risk of Parkinson's disease and progression
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105769
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Brain‐derived plasma p‐tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological change
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/alz.71773
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Tolerability and efficacy of full-body head-up tilt sleeping in Parkinson’s disease and multiple system atrophy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-026-01359-y
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genetic associations between post-traumatic stress disorder and REM-sleep behavior disorder
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-026-01397-6
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genome-wide association and population-tailored polygenic risk for Parkinson’s disease in Taiwan
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-026-01349-0
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Inter-assay and Inter-site Performance of Alpha-Synuclein Seed Amplification Assays in Synucleinopathies: A Multicenter 2 × 2 Protocol Comparison
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-026-00965-5
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The GBA1 p. E427K (p. E388K ) Variant Is a Risk Factor for Synucleinopathies: A Meta‐Analysis
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70367
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Regulator of G protein signaling 10: a critical regulator of chronic systemic inflammation in parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-026-03858-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aec0813
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.